Please use this identifier to cite or link to this item:
logo share SHARE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Human VRK1 is an early response gene and its loss causes a block in cell cycle progression

AuthorsValbuena, A.; López-Sánchez, Inmaculada; Lazo, Pedro A. CSIC ORCID
KeywordsVRK1, cell cycle, cancer
Issue Date20-Feb-2008
CitationPLoS ONE 3 (2): e1642 (2008)
AbstractBackground. In mammalian cells regulatory proteins controlling the cell cycle are necessary due to the requirements of living in a heterogeneous environment of cell-interactions and growth factors. VRK1 is a novel serine-threonine kinase that phosphorylates several transcription factors and is associated with proliferation phenotypes. Methodology/Principal Findings. In this report VRK1 has been identified as regulated in the cell cycle. VRK1 gene expression is activated by the addition of serum to starved cells, indicating it is required for the exit of G0 phase and entry in G1; a response that parallels the re-expression of MYC, FOS and CCND1 (cyclin D1) genes, suggesting that VRK1 is an early-response gene. VRK1 gene expression is also shutdown by serum withdrawal. The human VRK1 gene promoter cloned in a luciferase reporter responds similarly to serum. In response to serum, the level of VRK1 protein expression has a positive correlation with cell proliferation markers such as phosphorylated-Rb or PCNA, and is inversely correlated with cell cycle inhibitors as p27. The elimination of VRK1 by siRNA results in a G1 block in cell division, and in loss of phosphorylated-Rb, cyclin D1, and other proliferation markers. Elimination of VRK1 by siRNA induces a reduction of cell proliferation. VRK1 colocalizes with p63 in proliferating areas of squamous epithelium, and identifies a subpopulation in the basal layer. Conclusions/Significance. VRK1 is an immediate early response gene required for entry in G1, and due to its implication in normal cell proliferation and division, might be a new target for development of inhibitors of cellular proliferation.
Appears in Collections:(IBMCC) Artículos

Files in This Item:
File Description SizeFormat
PLOS One 3; e1642 (2008).pdf590,33 kBAdobe PDFThumbnail
Show full item record
Review this work

PubMed Central

checked on May 25, 2022


checked on May 21, 2022

Page view(s)

checked on May 24, 2022

Google ScholarTM



WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.